Wearable Technology for Monitoring Respiratory Rate and SpO2 of COVID-19 Patients

Authors

  • Shizuko Takahashi Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan and Sanno Medical Center, 8-5-35 Akasaka, Minato-ku, Tokyo 107-0052, Japan.
  • Eisuke Nakazawa Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Sakurako Ichinohe Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Aru Akabayashi Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan and Department of Biochemistry and Biophysics, School of Medicine and Dentistry Center for RNA Biology, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA.
  • Akira Akabayashi Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan and Division of Medical Ethics, School of Medicine, New York University, 227 East 30th Street, New York, NY 10016, USA.

DOI:

https://doi.org/10.9734/bpi/rdmms/v3/18568D

Keywords:

Wearable device, COVID-19, systematic review, monitoring, patients’ health status

Abstract

This review explored the indicators of COVID-19 surveillance, such as vitals, respiratory condition, temperature, oxygen saturation (SpO2), and activity levels using wearable devices. With a significant number of sudden home deaths reported worldwide due to coronavirus disease 2019 (COVID-19), wearable technology has emerged as a method for monitoring this infection. This systematic review used PubMed as the database, with the keywords “COVID-19”, “Diagnosis”, and “Wearable Devices”. The search was limited to studies published between 31 December 2019, and 8 July 2022, as the pandemic occurred during this period.  All types of articles with the keywords “COVID-19”, “Diagnosis”, and “Wearable Devices” were screened. Four reviewers independently screened the articles against the eligibility criteria and extracted the data using a data charting form. A total of 56 articles were on monitoring, of which 28 included SpO2 as a parameter. Although wearable devices are effective in the continuous monitoring of COVID-19 patients, further research on actual patients is necessary to determine the efficiency and effectiveness of wearable technology before policymakers can mandate its use. Although research on the effects of remote patient monitoring with pulse oximetry and respiratory rate on health outcomes is lacking, wearable devices have the potential to save hospital resources for patients who might benefit most from care escalation.

Published

2023-03-11

How to Cite

Shizuko Takahashi, Eisuke Nakazawa, Sakurako Ichinohe, Aru Akabayashi, & Akira Akabayashi. (2023). Wearable Technology for Monitoring Respiratory Rate and SpO2 of COVID-19 Patients. Research Developments in Medicine and Medical Science Vol. 3, 33–53. https://doi.org/10.9734/bpi/rdmms/v3/18568D